The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
16 11 2020
Historique:
received: 02 01 2020
accepted: 14 05 2020
revised: 05 05 2020
entrez: 17 11 2020
pubmed: 18 11 2020
medline: 22 6 2021
Statut: epublish

Résumé

Intellectual abilities and their clinical presentations are extremely heterogeneous in autism spectrum disorder (ASD). The main causes of ASD remain unclear. ASD is frequently associated with sleep disorders. Biologic rhythms are complex systems interacting with the environment and controlling several physiological pathways, including brain development and behavioral processes. Recent findings have shown that the deregulation of the core clock neurodevelopmental signaling is correlated with ASD clinical presentation. One of the main pathways involved in developmental cognitive disorders is the canonical WNT/β-catenin pathway. Circadian clocks have a main role in some tissues by driving circadian expression of genes involved in physiologic and metabolic functions. In ASD, the increase of the canonical WNT/β-catenin pathway is enhancing by the dysregulation of circadian rhythms. ASD progression is associated with a major metabolic reprogramming, initiated by aberrant WNT/β-catenin pathway, the aerobic glycolysis. This review focuses on the interest of circadian rhythms dysregulation in metabolic reprogramming in ASD through the aberrant upregulation of the canonical WNT/β-catenin pathway.

Identifiants

pubmed: 33199680
doi: 10.1038/s41398-020-01086-9
pii: 10.1038/s41398-020-01086-9
pmc: PMC7669888
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

400

Références

J Autism Dev Disord. 2011 Feb;41(2):175-84
pubmed: 20535539
Nature. 2012 Apr 04;485(7397):246-50
pubmed: 22495309
J Clin Endocrinol Metab. 1993 Feb;76(2):295-301
pubmed: 8381796
Cancer Res. 2008 Feb 15;68(4):1213-20
pubmed: 18281498
Cell Mol Life Sci. 2017 Oct;74(20):3649-3665
pubmed: 27543457
Nat Rev Neurosci. 2010 Aug;11(8):589-99
pubmed: 20631712
Development. 2003 Sep;130(18):4295-305
pubmed: 12900447
J Sleep Res. 2012 Jun;21(3):235-46
pubmed: 21988087
Mol Cell Biol. 2008 Jun;28(12):3894-904
pubmed: 18378692
Neurosci Biobehav Rev. 2010 Apr;34(5):755-68
pubmed: 19963005
Front Pediatr. 2015 Feb 23;3:1
pubmed: 25756039
Cell Biochem Funct. 2013 Mar;31(2):166-72
pubmed: 22961668
Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R271-7
pubmed: 16987893
PLoS One. 2008;3(11):e3815
pubmed: 19043581
PLoS One. 2010 Dec 23;5(12):e15330
pubmed: 21203463
Nat Rev Neurosci. 2010 Aug;11(8):539-51
pubmed: 20648061
J Autism Dev Disord. 2012 Aug;42(8):1729-37; author reply 1738
pubmed: 22160300
Clin Chim Acta. 1994 Sep;229(1-2):205-7
pubmed: 7988051
Neuron. 2011 Jun 9;70(5):898-907
pubmed: 21658583
PLoS One. 2016 Mar 31;11(3):e0152833
pubmed: 27031698
FASEB J. 2005 Aug;19(10):1296-8
pubmed: 15919761
Neuropsychopharmacology. 2018 Feb;43(3):459-468
pubmed: 28776581
Invest Clin. 1992;33(1):13-31
pubmed: 1391074
Curr Biol. 2002 Apr 2;12(7):551-7
pubmed: 11937023
J Pediatr Neurosci. 2015 Apr-Jun;10(2):146-8
pubmed: 26167220
EMBO J. 2014 Jul 1;33(13):1420-2
pubmed: 24843042
J Neurodev Disord. 2011 Jun;3(2):162-74
pubmed: 21533542
J Biol Rhythms. 2018 Feb;33(1):5-14
pubmed: 29277155
Biology (Basel). 2019 Mar 11;8(1):
pubmed: 30862123
J Med Genet. 1994 Apr;31(4):312-6
pubmed: 8071957
Brain Dev. 1999 Dec;21(8):570
pubmed: 10598064
Dev Med Child Neurol. 2005 Mar;47(3):185-9
pubmed: 15739723
Neuron. 2015 Apr 8;86(1):264-75
pubmed: 25801703
Mol Autism. 2012 Oct 19;3(1):10
pubmed: 23083465
Nat Rev Mol Cell Biol. 2009 Jul;10(7):468-77
pubmed: 19536106
Nat Rev Neurosci. 2012 Jan 18;13(2):107-20
pubmed: 22251963
Adv Genet. 2011;74:13-53
pubmed: 21924974
Sleep Med Rev. 2011 Dec;15(6):379-87
pubmed: 21393033
Life Sci. 2018 Jan 15;193:141-152
pubmed: 29079469
J Autism Dev Disord. 1995 Dec;25(6):641-54
pubmed: 8720032
J Cell Sci. 2012 Feb 1;125(Pt 3):561-9
pubmed: 22389395
Genes Dev. 2007 May 1;21(9):1037-49
pubmed: 17437992
Oncogene. 2005 Aug 25;24(36):5552-60
pubmed: 16007214
Int J Mol Sci. 2017 Nov 27;18(12):
pubmed: 29186898
FASEB J. 2012 Sep;26(9):3602-13
pubmed: 22661008
Nat Rev Neurosci. 2005 Nov;6(11):877-88
pubmed: 16261181
Transl Psychiatry. 2015 Mar 10;5:e525
pubmed: 25756808
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
pubmed: 10318916
Exp Gerontol. 2001 Jul;36(7):1083-100
pubmed: 11404053
Chronobiol Int. 2003 Sep;20(5):741-74
pubmed: 14535352
PLoS One. 2008;3(11):e3755
pubmed: 19015734
J Biol Chem. 2003 Sep 26;278(39):37024-31
pubmed: 12857724
Mol Psychiatry. 2008 Jan;13(1):90-8
pubmed: 17505466
Oncotarget. 2017 Sep 23;8(52):90579-90604
pubmed: 29163854
EMBO J. 1997 Jul 1;16(13):3797-804
pubmed: 9233789
J Neurosci. 2015 Jul 15;35(28):10252-67
pubmed: 26180201
Cell Mol Life Sci. 2008 Dec;65(24):3981-99
pubmed: 18766298
Bone. 2004 Jul;35(1):83-95
pubmed: 15207744
Biochimie. 2016 May;124:178-186
pubmed: 25926044
Nat Rev Genet. 2005 Jul;6(7):544-56
pubmed: 15951747
Hum Mol Genet. 2016 Jul 1;25(13):2738-2751
pubmed: 27131348
Cell. 2009 Oct 16;139(2):285-98
pubmed: 19837032
Cell Rep. 2013 Dec 12;5(5):1330-41
pubmed: 24316074
Mol Psychiatry. 2007 Jun;12(6):581-92
pubmed: 17264841
J Physiol Paris. 2016 Nov;110(4 Pt B):434-438
pubmed: 28625682
Cell. 2012 Apr 27;149(3):525-37
pubmed: 22521361
J Biochem. 2009 Mar;145(3):289-97
pubmed: 19106159
PLoS One. 2012;7(10):e46885
pubmed: 23056511
J Autism Dev Disord. 1998 Aug;28(4):345-6
pubmed: 9711493
Funct Integr Genomics. 2011 Sep;11(3):383-8
pubmed: 21465271
Trends Neurosci. 2014 Feb;37(2):95-105
pubmed: 24387789
Trends Biochem Sci. 2010 Mar;35(3):161-8
pubmed: 19884009
EMBO J. 2014 Jul 1;33(13):1454-73
pubmed: 24825347
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
FASEB J. 2012 Aug;26(8):3453-63
pubmed: 22611086
Oncotarget. 2015 Jan 20;6(2):651-61
pubmed: 25528771
Sleep Med Rev. 2009 Dec;13(6):403-11
pubmed: 19398354
Am J Med Genet. 2001 Jul 8;105(5):406-13
pubmed: 11449391
Oncogene. 2006 Dec 4;25(57):7545-53
pubmed: 17143299
Transl Psychiatry. 2013 Sep 03;3:e301
pubmed: 24002087
Cell. 1999 Jan 22;96(2):271-90
pubmed: 9988221
PLoS One. 2014 Aug 06;9(8):e102776
pubmed: 25099274
Pediatr Ann. 2009 Mar;38(3):167-70, 172
pubmed: 19353907
Trends Neurosci. 1990 Nov;13(11):457-64
pubmed: 1701579
Mol Cell. 2010 Jul 30;39(2):171-83
pubmed: 20670887
Int J Mol Sci. 2013 Oct 14;14(10):20508-42
pubmed: 24129182
Mol Brain. 2018 Jan 4;11(1):1
pubmed: 29301575
J Autism Dev Disord. 2008 Oct;38(9):1625-33
pubmed: 18293072
Nature. 2002 Aug 29;418(6901):935-41
pubmed: 12198538
J Neuroimmune Pharmacol. 2012 Dec;7(4):725-30
pubmed: 23114888
Neuromolecular Med. 2018 Jun;20(2):174-204
pubmed: 29572723
Annu Rev Neurosci. 2012;35:445-62
pubmed: 22483041
Curr Opin Genet Dev. 2010 Feb;20(1):51-6
pubmed: 19942427
Front Behav Neurosci. 2012 Nov 27;6:83
pubmed: 23205007
Brain Dev. 2016 Jan;38(1):91-9
pubmed: 25957987
Sleep. 2005 Apr;28(4):395-409
pubmed: 16171284
J Pineal Res. 2008 Jan;44(1):57-64
pubmed: 18078449
Minerva Pediatr. 2006 Apr;58(2):109-20
pubmed: 16835571
Cancer Cell. 2003 Aug;4(2):147-58
pubmed: 12957289
Pediatr Neurol. 2012 Oct;47(4):242-51
pubmed: 22964437
J Cell Biol. 2006 Jul 3;174(1):127-39
pubmed: 16818724
Comp Med. 2015 Dec;65(6):473-85
pubmed: 26678364
Organogenesis. 2008 Apr;4(2):60-7
pubmed: 19122781
Am J Hum Genet. 2016 Jan 7;98(1):58-74
pubmed: 26749308
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a015081
pubmed: 23085770
J Clin Invest. 2014 Sep;124(9):3825-46
pubmed: 25083995
Nat Genet. 2011 Jun;43(6):585-9
pubmed: 21572417
Proc Biol Sci. 2013 Jul 03;280(1765):20130035
pubmed: 23825203
J Biol Chem. 2008 Dec 12;283(50):34495-9
pubmed: 18945681
J Neurosci. 2000 Nov 1;20(21):8138-43
pubmed: 11050136
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4129-34
pubmed: 21325052
J Pineal Res. 2016 Mar;60(2):167-77
pubmed: 26607298
Biochim Biophys Acta. 2016 Oct;1863(10):2436-42
pubmed: 26826034
Science. 1998 Jun 5;280(5369):1564-9
pubmed: 9616112
J Neurodev Disord. 2016 Dec 5;8:45
pubmed: 27980692
Annu Rev Cell Dev Biol. 2004;20:781-810
pubmed: 15473860
Metab Brain Dis. 2017 Dec;32(6):1983-1997
pubmed: 28831647
Front Mol Neurosci. 2014 Apr 16;7:27
pubmed: 24795561
Neuron. 2006 May 4;50(3):377-88
pubmed: 16675393
J Biol Chem. 2007 Jul 13;282(28):20534-43
pubmed: 17502379
Tumour Biol. 2013 Aug;34(4):1991-2002
pubmed: 23625692
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Aging Dis. 2017 May 2;8(3):314-333
pubmed: 28580187
Nature. 2011 Nov 09;480(7376):209-14
pubmed: 22080954
J Autism Dev Disord. 2006 Nov;36(8):1137-40
pubmed: 17151801
Front Neurosci. 2014 Nov 06;8:331
pubmed: 25414627
Open Ophthalmol J. 2014 Jul 23;8:39-47
pubmed: 25191529
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5474-9
pubmed: 9576906
Cell Biochem Biophys. 2001;34(2):237-56
pubmed: 11898866
Nat Rev Neurosci. 2010 Feb;11(2):77-86
pubmed: 20010950
Mol Psychiatry. 2014 Oct;19(10):1133-42
pubmed: 24934177
Science. 2012 Dec 21;338(6114):1619-22
pubmed: 23160955
Front Physiol. 2017 May 30;8:352
pubmed: 28620312
Mol Cell Biol. 2007 Nov;27(21):7381-93
pubmed: 17785433
Neural Plast. 2016;2016:9603751
pubmed: 26881141
Annu Rev Physiol. 2010;72:517-49
pubmed: 20148687
Ann Med. 2014 Jun;46(4):221-32
pubmed: 24779962
Mol Neuropsychiatry. 2017 Feb;2(4):219-246
pubmed: 28277568
Rev Neurosci. 2018 Jan 26;29(1):71-91
pubmed: 28822229
Cell Metab. 2013 May 7;17(5):745-55
pubmed: 23623748
Neurosci Bull. 2018 Jun;34(3):573-588
pubmed: 29582250
Curr Issues Mol Biol. 2019;31:21-44
pubmed: 31160540
Handb Clin Neurol. 2012;106:697-713
pubmed: 22608653
Cell. 2002 Dec 27;111(7):919-22
pubmed: 12507418
Mol Psychiatry. 2015 Sep;20(9):1132-8
pubmed: 25288137
Front Endocrinol (Lausanne). 2017 Mar 08;8:42
pubmed: 28337174
Mol Psychiatry. 2012 Mar;17(3):290-314
pubmed: 21263444
J Med Genet. 2015 Feb;52(2):128-34
pubmed: 25527629
Nat Rev Cancer. 2009 Dec;9(12):886-96
pubmed: 19935677
Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):351-4
pubmed: 17221838
Annu Rev Biochem. 2004;73:39-85
pubmed: 15189136
Cold Spring Harb Symp Quant Biol. 2007;72:645-54
pubmed: 18419324
Cell Stem Cell. 2011 Oct 4;9(4):298-310
pubmed: 21982230
J Mol Neurosci. 2017 Aug;62(3-4):368-379
pubmed: 28689265
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Cancer Res. 2002 Sep 15;62(18):5126-8
pubmed: 12234972
Biol Psychiatry. 2005 Jan 15;57(2):134-8
pubmed: 15652871
Sci Rep. 2017 Mar 06;7:43945
pubmed: 28262759

Auteurs

Alexandre Vallée (A)

Department of Clinical Research and Innovation (DRCI), Hôpital Foch, Suresnes, France. alexandre.g.vallee@gmail.com.

Yves Lecarpentier (Y)

Centre de Recherche Clinique, Grand Hôpital de l'Est Francilien (GHEF), Meaux, France.

Rémy Guillevin (R)

DACTIM-MIS, Laboratory of Mathematics and Applications (LMA), UMR CNRS 7348, University of Poitiers, Poitiers, France.

Jean-Noël Vallée (JN)

DACTIM-MIS, Laboratory of Mathematics and Applications (LMA), UMR CNRS 7348, University of Poitiers, Poitiers, France.
CHU Amiens Picardie, University of Picardie Jules Verne (UPJV), Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH